Tetraphase Pharmaceuticals, Inc. Announces Management Changes
January 11, 2016 at 04:06 pm
On January 6, 2016 the Board of Directors of Tetraphase Pharmaceuticals, Inc. elected Christopher Watt the Company's principal financial officer and principal accounting officer until a chief financial officer is named. On January 4, 2016, the company filed a Current Report on Form 8-K announcing that David Lubner submitted his resignation as senior vice president and chief financial officer of the company effective January 8, 2016. Mr. Watt currently serves as the Company's Vice President, Finance. Mr. Watt, 51, has served as vice president, finance since July 2015. Prior to joining the Company, from 2004 to July 2015, Mr. Watt held a variety of leadership positions at Biogen Inc., most recently serving as senior director, global commercial finance. Mr. Watt holds a BA from Colby College and an
MBA from the University of Michigan.